These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28849151)

  • 1. Effect of silencing the T‑Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells.
    Du WL; Fang Q; Chen Y; Teng JW; Xiao YS; Xie P; Jin B; Wang JQ
    Mol Med Rep; 2017 Nov; 16(5):6050-6058. PubMed ID: 28849151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
    D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
    Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
    Xu K; Liu B; Liu Y
    Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
    Ling YX; Tao J; Fang SF; Hui Z; Fang QR
    Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell.
    Pan B; Zheng S; Liu C; Xu Y
    Mol Biol Rep; 2013 Jan; 40(1):27-33. PubMed ID: 23117283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.
    Chen Q; Zhu L; Zheng B; Wang J; Song X; Zheng W; Wang L; Yang D; Wang J
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
    Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
    Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
    Nalla AK; Estes N; Patel J; Rao JS
    Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of tbx2 in pancreatic cancer.
    Duo S; Tiao-Dong T; Lei Z; Wei W; Hong-Li S; Xian-Wei D
    Asian Pac J Cancer Prev; 2009; 10(1):118-22. PubMed ID: 19469638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.
    Hoyne G; Rudnicka C; Sang QX; Roycik M; Howarth S; Leedman P; Schlaich M; Candy P; Matthews V
    BMC Cancer; 2016 Feb; 16():151. PubMed ID: 26912236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
    Wansleben S; Davis E; Peres J; Prince S
    Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.
    Mo RJ; Lu JM; Wan YP; Hua W; Liang YX; Zhuo YJ; Kuang QW; Liu YL; He HC; Zhong WD
    Curr Mol Med; 2017; 17(1):70-78. PubMed ID: 28231752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
    Dasari C; Yaghnam DP; Walther R; Ummanni R
    Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
    Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
    Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.